Peripartum Cardiomyopathy
Key Points
- Peripartum cardiomyopathy is a rare but high-risk cause of maternal heart failure in late pregnancy or early postpartum.
- Symptoms can be mistaken for expected third-trimester discomforts, delaying recognition.
- Management goals are symptom relief, preload/afterload optimization, and hemodynamic stabilization.
- Medication plans require pregnancy and lactation safety checks.
- Delivery timing and route depend on maternal hemodynamic stability and fetal maturity.
Pathophysiology
Peripartum cardiomyopathy is an acquired myocardial disorder with left ventricular systolic dysfunction that appears near term or shortly after birth. Reduced contractility lowers forward flow and promotes pulmonary congestion, exercise intolerance, and volume-overload findings similar to other forms of heart failure.
Clinical recognition can be delayed because dyspnea, fatigue, edema, and nocturia may overlap with expected pregnancy symptoms. Untreated decompensation increases risk for hypoxemia, hypotension, dysrhythmia, and maternal-fetal instability.
Classification
- Stable peripartum cardiomyopathy: Symptoms present without severe hypoxemia, persistent hypotension, or shock physiology.
- Acute decompensated peripartum cardiomyopathy: Pulmonary edema, hemodynamic instability, or severe low-output findings requiring urgent critical-care escalation.
Nursing Assessment
NCLEX Focus
Prioritize distinction between expected pregnancy discomfort and heart-failure decompensation cues requiring urgent escalation.
- Assess dyspnea pattern, including orthopnea, resting dyspnea, and activity intolerance.
- Assess edema distribution, fatigue severity, palpitations, cough, chest pain, and light-headedness.
- Assess blood pressure trends (including orthostatic changes), oxygenation, and signs of pulmonary congestion.
- Assess for dysrhythmia complications and worsening perfusion (cool extremities, oliguria, altered mentation).
- Trend maternal status with fetal well-being indicators and delivery-readiness planning.
Nursing Interventions
- Escalate suspected decompensation rapidly and support oxygenation, hemodynamics, and continuous reassessment.
- Implement multidisciplinary planning with obstetric, cardiology, anesthesia, and neonatal teams.
- Prepare for urgent delivery when maternal instability persists despite treatment; stabilize maternal status before delivery whenever possible.
- In clinically stable patients, support monitored vaginal-delivery pathways when appropriate.
- Provide postpartum teaching on medication adherence, decompensation red flags, and follow-up echocardiographic reassessment.
Pregnancy Medication Contraindication Risk
ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists are contraindicated during pregnancy and should not be used antenatally.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| Pregnancy-compatible HF support classes | Diuretics, selected beta-blockers, hydralazine/nitrates, digoxin | Use for congestion and symptom support while monitoring maternal BP, perfusion, and fetal status. |
| Hemodynamic support agents | Inotrope/vasopressor pathways (for example norepinephrine context) | Reserve for hypotension or persistent low-output decompensation with close ICU-level monitoring. |
| Contraindicated antenatal classes | ace-inhibitors, ARBs, mineralocorticoid receptor antagonists | Avoid during pregnancy because of fetal risk. |
Clinical Judgment Application
Clinical Scenario
A 31-year-old client at 37 weeks has progressive orthopnea, ankle edema, palpitations, and new dry cough with reduced activity tolerance.
- Recognize Cues: Progressive cardiopulmonary findings exceed typical pregnancy discomfort patterns.
- Analyze Cues: Findings suggest peripartum cardiomyopathy with evolving heart-failure physiology.
- Prioritize Hypotheses: Maternal decompensation risk is the immediate priority because fetal status depends on maternal stabilization.
- Generate Solutions: Escalate to multidisciplinary team, initiate oxygen/hemodynamic support, and prepare delivery contingency planning.
- Take Action: Implement ordered monitoring and treatment while continuously reassessing maternal and fetal response.
- Evaluate Outcomes: Dyspnea and hemodynamics improve, and delivery plan proceeds with maternal-fetal stability.
Related Concepts
- heart-failure - Peripartum cardiomyopathy presents as pregnancy-associated systolic heart failure.
- preexisting-conditions-placing-delivery-at-risk - Cardiac disease substantially changes intrapartum and postpartum risk planning.
- deep-vein-thrombosis - Peripartum cardiopulmonary deterioration requires overlap assessment for thromboembolic causes.
- cardiovascular-risk-screening-in-persons-afab - Baseline cardiovascular risk assessment supports earlier high-risk pregnancy planning.
Self-Check
- Which symptom pattern should prompt escalation for suspected peripartum cardiomyopathy rather than routine third-trimester discomfort?
- Why must ACE inhibitors and ARBs be avoided during pregnancy in this condition?
- How does maternal hemodynamic stability determine delivery timing and route?